Oracle Life Sciences has been named a 'Leader' in the Everest Group Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix® Assessment 2024. This designation underscores Oracle's ...

Among 15 leading service providers evaluated, Concentrix earned Highest Leader positioning, based on market impact, the ability to deliver services successfully, its strategic integration of AI ...

These factors, among others, have contributed to Concentrix' recognition as a Leader in Everest Group's B2B Sales Services PEAK Matrix Assessment 2024.” Concentrix outperformed in categories ...

Concentrix Corporation has been recognized as the Highest Leader in Everest Group's inaugural B2B Sales Services PEAK Matrix® Assessment, outpacing 15 other service providers evaluated.

BMO Capital Markets downgraded Everest Group (NYSE:EG) to Market Perform from Outperform since the company has become more of a restructuring story than analyst Michael Zaremski had previously ...

Read Our Latest Research Report on EG Everest Group Stock Down 4.2 % EG opened at $352.06 on Thursday. Everest Group, Ltd. has a one year low of $343.76 and a one year high of $407.30. The company ...

Everest Group's shares have underperformed, losing 4% over the past year, with disappointing underwriting results and a significant Q4 loss surprising investors. The company has added $1.7 billion ...

Everest is to announce its FY24 and quarterly earnings next Monday. The company said it expects to report full-year non-GAAP net operating income in the range of $1.2 billion to $1.3 billion.